146 related articles for article (PubMed ID: 27826300)
1. Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features.
García-González PA; Schinnerling K; Sepúlveda-Gutiérrez A; Maggi J; Hoyos L; Morales RA; Mehdi AM; Nel HJ; Soto L; Pesce B; Molina MC; Cuchacovich M; Larrondo ML; Neira Ó; Catalán DF; Hilkens CM; Thomas R; Verdugo RA; Aguillón JC
Front Immunol; 2016; 7():458. PubMed ID: 27826300
[TBL] [Abstract][Full Text] [Related]
2. A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines.
García-González P; Morales R; Hoyos L; Maggi J; Campos J; Pesce B; Gárate D; Larrondo M; González R; Soto L; Ramos V; Tobar P; Molina MC; Pino-Lagos K; Catalán D; Aguillón JC
J Transl Med; 2013 May; 11():128. PubMed ID: 23706017
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone and Monophosphoryl Lipid A-Modulated Dendritic Cells Promote Antigen-Specific Tolerogenic Properties on Naive and Memory CD4
Maggi J; Schinnerling K; Pesce B; Hilkens CM; Catalán D; Aguillón JC
Front Immunol; 2016; 7():359. PubMed ID: 27698654
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone and Monophosphoryl Lipid A Induce a Distinctive Profile on Monocyte-Derived Dendritic Cells through Transcriptional Modulation of Genes Associated With Essential Processes of the Immune Response.
García-González PA; Schinnerling K; Sepúlveda-Gutiérrez A; Maggi J; Mehdi AM; Nel HJ; Pesce B; Larrondo ML; Aravena O; Molina MC; Catalán D; Thomas R; Verdugo RA; Aguillón JC
Front Immunol; 2017; 8():1350. PubMed ID: 29109727
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Tolerogenic Features on Dexamethasone-Modulated MPLA-Activated Dendritic Cells by MYC.
García-González PA; Maggi J; Schinnerling K; Sepúlveda-Gutiérrez A; Soto L; Neira O; Mehdi AM; Nel HJ; Pesce B; Aravena O; Molina MC; Catalán D; Thomas R; Verdugo RA; Aguillón JC
Front Immunol; 2019; 10():1171. PubMed ID: 31191540
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.
Harry RA; Anderson AE; Isaacs JD; Hilkens CM
Ann Rheum Dis; 2010 Nov; 69(11):2042-50. PubMed ID: 20551157
[TBL] [Abstract][Full Text] [Related]
7. NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment.
Dáňová K; Klapetková A; Kayserová J; Šedivá A; Špíšek R; Jelínková LP
Oncotarget; 2015 Jun; 6(16):14123-38. PubMed ID: 26053099
[TBL] [Abstract][Full Text] [Related]
8. Comparison of media and serum supplementation for generation of monophosphoryl lipid A/interferon-γ-matured type I dendritic cells for immunotherapy.
Kolanowski ST; Sritharan L; Lissenberg-Thunnissen SN; Van Schijndel GM; Van Ham SM; ten Brinke A
Cytotherapy; 2014 Jun; 16(6):826-34. PubMed ID: 24529557
[TBL] [Abstract][Full Text] [Related]
9. Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing the adjuvant dosage.
Fichter M; Dedters M; Pietrzak-Nguyen A; Pretsch L; Meyer CU; Strand S; Zepp F; Baier G; Landfester K; Gehring S
Vaccine; 2015 Feb; 33(7):838-46. PubMed ID: 25573037
[TBL] [Abstract][Full Text] [Related]
10. Tolerogenic dendritic cells modified by tacrolimus suppress CD4(+) T-cell proliferation and inhibit collagen-induced arthritis in mice.
Ren Y; Yang Y; Yang J; Xie R; Fan H
Int Immunopharmacol; 2014 Jul; 21(1):247-54. PubMed ID: 24836681
[TBL] [Abstract][Full Text] [Related]
11. Induction of tolerogenic vs immunogenic dendritic cells (DCs) in the presence of GM-CSF is regulated by the strength of signaling from monophosphoryl lipid A (MPLA) in association with glutathione and fetal hemoglobin gamma-chain.
Khatri I; Alexander C; Brandenburg K; Fournier K; Mach JP; Rietschel ET; Ulmer AJ; Terzioglu E; Waelli T; Gorczynski RM
Immunol Lett; 2009 May; 124(1):44-9. PubMed ID: 19379773
[TBL] [Abstract][Full Text] [Related]
12. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.
Torres-Aguilar H; Aguilar-Ruiz SR; González-Pérez G; Munguía R; Bajaña S; Meraz-Ríos MA; Sánchez-Torres C
J Immunol; 2010 Feb; 184(4):1765-75. PubMed ID: 20083662
[TBL] [Abstract][Full Text] [Related]
13. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific tolerogenic dendritic cells ameliorate the severity of murine collagen-induced arthritis.
Ning B; Wei J; Zhang A; Gong W; Fu J; Jia T; Yang SY
PLoS One; 2015; 10(6):e0131152. PubMed ID: 26107250
[TBL] [Abstract][Full Text] [Related]
15. MPLA shows attenuated pro-inflammatory properties and diminished capacity to activate mast cells in comparison with LPS.
Schülke S; Flaczyk A; Vogel L; Gaudenzio N; Angers I; Löschner B; Wolfheimer S; Spreitzer I; Qureshi S; Tsai M; Galli S; Vieths S; Scheurer S
Allergy; 2015 Oct; 70(10):1259-68. PubMed ID: 26081583
[TBL] [Abstract][Full Text] [Related]
16. The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization.
Ten Brinke A; Karsten ML; Dieker MC; Zwaginga JJ; van Ham SM
Vaccine; 2007 Oct; 25(41):7145-52. PubMed ID: 17719152
[TBL] [Abstract][Full Text] [Related]
17. The role of dendritic cells and their immunometabolism in rheumatoid arthritis.
Suwa Y; Nagafuchi Y; Yamada S; Fujio K
Front Immunol; 2023; 14():1161148. PubMed ID: 37251399
[TBL] [Abstract][Full Text] [Related]
18. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.
Zhao Y; Zhang A; Du H; Guo S; Ning B; Yang S
Rheumatol Int; 2012 Apr; 32(4):837-44. PubMed ID: 21904923
[TBL] [Abstract][Full Text] [Related]
20. Human tolerogenic dendritic cells generated with protein kinase C inhibitor are optimal for functional regulatory T cell induction - A comparative study.
Adnan E; Matsumoto T; Ishizaki J; Onishi S; Suemori K; Yasukawa M; Hasegawa H
Clin Immunol; 2016 Dec; 173():96-108. PubMed ID: 27658741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
